47 / 74
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 5, September/October 2018
AFRICA
309
Fail
2005;
11
: S15–20.
10. Bettencourt P, Azevedo A, Pimenta J, Friões F, Ferreira S, Ferreira A.
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital
discharge in heart failure patients.
Circulation
2004;
110
: 2168–2174.
11. Flores-Blanco PJ, Manzano-Fernández S, Pérez-Calvo JI, Pastor-
Pérez FJ, Ruiz-Ruiz FJ, Carrasco-Sánchez FJ,
et al
. Cystatin C-based
CKD-EPI equations and N-terminal pro-B-type natriuretic peptide
for predicting outcomes in acutely decompensated heart failure.
Clin
Cardiol
2015;
38
: 106–113.
12. JCS Joint Working Group. Guidelines for treatment of acute heart fail-
ure (JCS 2011).
Circ J
2013;
77
: 2157–2201.
13. Swedberg K, Cleland J, DargieH,Drexler H, Follath F, Komajda M,
et
al
. Guidelines for the diagnosis and treatment of chronic heart failure:
executive summary (update 2005): the Task Force for the Diagnosis
and Treatment of Chronic Heart Failure of the European Society of
Cardiology.
Eur Heart J
2005;
26
: 1115–1140.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more
accurate method to estimate glomerular filtration rate from serum
creatinine: a new prediction equation. Modification of Diet in Renal
Disease Study Group.
Ann Intern Med
1999;
130
: 461–470.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from
serum creatinine.
Nephron
1976;
16
: 31–41.
16. Otto CM.
Textbook of Clinical Echocardiography.
3rd edn. Philadelphia,
USA: WB Saunders, 2004: 131–165.
17. Shlipak MG, Massie BM. The clinical challenge of cardiorenal
syndrome.
Circulation
2004;
110
: 1514–1517.
18. Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick
SG,
et al.
Worsening renal function: what is a clinically meaningful
change in creatinine during hospitalization with heart failure?
J Card
Fail
2003;
9
: 13–25.
19. Damman K, Voors AA, Navis G, van Veldhuisen DJ, Hillege HL. The
cardiorenal syndrome in heart failure.
Prog Cardiovasc Dis
2011;
54
:
144–153.
20. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R,
et al
. Worsening renal function in patients hospitalised for acute heart
failure: clinical implications and prognostic significance.
Eur J Heart
Fail
2014;
10
: 188–195.
21. Testani JM, McCauley BD, Chen J, Coca SG, Cappola TP, Kimmel SE.
Clinical characteristics and outcomes of patients with improvement in
renal function during the treatment of decompensated heart failure.
J
Card Fail
2011;
17
: 993–1000.
22. Jaisuresh K, Sharma RK, Mehrothra S, Kaul A, Badauria DS, Gupta
A,
et al
. Cystatin C as a marker of glomerular filtration rate in voluntary
kidney donors.
Exp Clin Transplant
2012;
10
: 14–17.
23. Inazumi H, Koyama S, Tanada Y, Fujiwara H, Takatsu Y, Sato Y.
Prognostic significance of changes in cystatin C during treatment of
acute cardiac decompensation
. J Cardiol
2016;
67
: 98–103.
24. Rafouli-Stergiou P, Parissis J, Farmakis D, Bistola V, Nikolaou M,
Vasiliadis K,
et al
. Prognostic value of in-hospital change in cystatin C
in patients with acutely decompensated heart failure and renal dysfunc-
tion.
Int J Cardiol
2015;
182
: 74–76.
25. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Piña IL,
et
al.
Characterization and prognostic value of persistent hyponatremia in
patients with severe heart failure in the ESCAPE Trial.
Arch Intern Med
2007;
167
: 1998–2005.
26. Ahmadi A, Etemad K, Khaledifar A. Risk factors for heart failure
in a cohort of patients with newly diagnosed myocardial infarction:
a matched, case-control study in Iran.
Epidemiol Health
2016;
38
:
e2016019.
27. Tang WH, Dupont M, Hernandez AF, Voors AA, Hsu AP, Felker GM,
et al
. Comparative assessment of short-term adverse events in acute
heart failure with cystatin C and other estimates of renal function:
results from the ASCEND-HF trial.
J Am Coll Cardiol Heart Fail
2015;
3
: 40–49.